MRX:NASDAQMarex Group plc Analysis
Data as of 2026-05-19 - not real-time
$56.29
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Marex Group plc is trading comfortably above its 20‑day and 50‑day moving averages and remains near its 200‑day SMA, indicating a sustained bullish bias. The RSI sits in the low‑60s, suggesting upward momentum but still below the classic over‑bought threshold, while the MACD histogram has turned slightly negative, hinting at a short‑term cautionary signal.
Fundamentally, the company delivers a robust 55% revenue growth rate, gross margins near 69%, and an operating margin above 13%, positioning it well ahead of many peers. Valuation metrics are attractive, with a trailing PE well below the industry average and a forward PE under 11, while the dividend payout ratio is modest at roughly 14%, supporting dividend sustainability. Upcoming catalysts include the Q1 earnings release on May 6 and an ex‑dividend date on May 18, which may add short‑term volatility but also present buying opportunities for income‑focused investors.
Fundamentally, the company delivers a robust 55% revenue growth rate, gross margins near 69%, and an operating margin above 13%, positioning it well ahead of many peers. Valuation metrics are attractive, with a trailing PE well below the industry average and a forward PE under 11, while the dividend payout ratio is modest at roughly 14%, supporting dividend sustainability. Upcoming catalysts include the Q1 earnings release on May 6 and an ex‑dividend date on May 18, which may add short‑term volatility but also present buying opportunities for income‑focused investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Upcoming Q1 earnings release may cause price swing
- MACD histogram turning negative signals near‑term caution
- RSI approaching over‑bought levels near resistance
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high gross margins
- Undervalued relative to industry PE and forward PE
- Low dividend payout ratio indicating sustainable income
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Diversified capital‑markets platform with expanding client base
- Continued growth potential in commodity and digital‑asset services
- Attractive valuation and modest dividend enhancing total return
Key Metrics & Analysis
Financial Health
Revenue Growth55.10%
Profit Margin10.63%
P/E Ratio12.8
ROE29.06%
ROA1.14%
Debt/Equity974.13
P/B Ratio3.2
Industry P/E16.7
Technical Analysis
TrendBullish
RSI62.4
Support$47.81
Resistance$58.62
MA 20$53.68
MA 50$47.12
MA 200$38.83
MACDBearish
VolumeIncreasing
Fear & Greed Index89.5
Valuation
Target Price$57.13
Upside/Downside1.48%
GradeUndervalued
TypeGrowth
Dividend Yield1.14%
Risk Assessment
Beta0.80
Volatility44.77%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.